Skip to content

Klaus Tapio Olkkola

1 paper in the library · 55 citations · publishing 2009

Papers

Sort Most recent Most cited

Clarithromycin, a potent inhibitor of CYP3A, greatly increases exposure to oral S‐ketamine

European Journal of Pain November 8, 2009 Nora M. Hagelberg, Marko A. Peltoniemi, Teijo I. Saari et al. 55 citations

BACKGROUND: Oral ketamine is used as an adjuvant in the treatment of refractory neuropathic and cancer-related pain. Drug interactions may alter the analgesic or other effects of ketamine. AIM AND METHODS: The aim of the study was to investigate the effect of cytochrome P450 3A enzyme inhibition with clarithromycin on the pharmacokinetics and pharmacodynamics of oral S-ketamine in a randomized...